Borderline Ovarian Epithelial Tumor — Trials

Borderline Ovarian Epithelial Tumor — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02520115	Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer	completed	Phase 1	50	Barbara Ann Karmanos Cancer InstituteOTHER	1	Aug 14, 2019	clinicaltrials
NCT00031681	7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	completed	Phase 1	41	National Cancer Institute (NCI)NIH	1	Sep 30, 2013	clinicaltrials

Data updated 22 days agoSource updated Aug 14, 2019source: clinicaltrials